A new five-year project led by North Carolina State University will sponsor an international collaborative research and training program in biomanufacturing science and technology.
The effort focuses on the next generation of biopharmaceutical manufacturing – a rapidly evolving industry sector, critical to grant global access to powerful new biotherapeutics for treating a wide range of chronic and potentially lethal diseases. Biotherapeutics are large-molecule drugs produced by engineered organisms – including antibodies, enzymes, insulin and blood-clotting factors – as well as ingredients for gene therapy and regenerative medicine.
Read the full article